The Biosciences Fund (BioSF) is a competitive technology development and commercialisation program funded by the NSW Government and administered by the Office of the NSW Chief Scientist & Engineer (OCSE) within the NSW Department of Enterprise, Investment and Trade (DEIT).
The objective of the BioSF is to progress new and innovative devices and systems towards commercialisation within NSW across the branches of the biological sciences (biotechnology and life sciences), including biomanufacturing, genetic engineering, synthetic biology and agrifood.
The BioSF targets innovative devices/systems within Technology Readiness Levels (TRL) 3 – 7 and aims to help them move along the TRL scale, to commercialise their idea and attract large-scale private investment.
The NSW Government recognises the importance of capturing potential commercial applications of NSW research. By addressing gaps in the product life cycle between early-stage research and mature investment opportunities, the BioSF delivers grants to drive the commercialisation of highly innovative ideas into new devices, systems, processes or services.
The BioSF program complements the Physical Sciences Fund (PSF), a competitive technology development and commercialisation program delivered by OCSE since 2019. In 2023/24 the BioSF will provide up to $4.5 million funding for grants of between $200,000 to $2 million. A second round of BioSF will be held in 2025/26.
|Full applications requested
|Expert Panel undertakes final assessment
|Successful applicants announced
Note these dates are subject to change.
If you have questions regarding the BioSF, contact us at firstname.lastname@example.org
If you would like to receive further information about the BioSF or future programs and activities run by OCSE, please register using this form to be added to the mailing list.